133 related articles for article (PubMed ID: 27167773)
1. Ywhaz/14-3-3ζ Deletion Improves Glucose Tolerance Through a GLP-1-Dependent Mechanism.
Lim GE; Piske M; Lulo JE; Ramshaw HS; Lopez AF; Johnson JD
Endocrinology; 2016 Jul; 157(7):2649-59. PubMed ID: 27167773
[TBL] [Abstract][Full Text] [Related]
2. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release.
Chu ZL; Carroll C; Alfonso J; Gutierrez V; He H; Lucman A; Pedraza M; Mondala H; Gao H; Bagnol D; Chen R; Jones RM; Behan DP; Leonard J
Endocrinology; 2008 May; 149(5):2038-47. PubMed ID: 18202141
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Glucose Control Following Vertical Sleeve Gastrectomy Does Not Require a β-Cell Glucagon-Like Peptide 1 Receptor.
Douros JD; Lewis AG; Smith EP; Niu J; Capozzi M; Wittmann A; Campbell J; Tong J; Wagner C; Mahbod P; Seeley R; D'Alessio DA
Diabetes; 2018 Aug; 67(8):1504-1511. PubMed ID: 29759973
[TBL] [Abstract][Full Text] [Related]
4. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
[TBL] [Abstract][Full Text] [Related]
5. GLP-1 signaling is required for improvement of glucose tolerance by osteocalcin.
Mizokami A; Mukai S; Gao J; Kawakubo-Yasukochi T; Otani T; Takeuchi H; Jimi E; Hirata M
J Endocrinol; 2020 Feb; 244(2):285-296. PubMed ID: 31693486
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular fraction of wheat protein hydrolysate stimulates glucagon-like peptide-1 secretion in an enteroendocrine L cell line and improves glucose tolerance in rats.
Kato M; Nakanishi T; Tani T; Tsuda T
Nutr Res; 2017 Jan; 37():37-45. PubMed ID: 28215313
[TBL] [Abstract][Full Text] [Related]
7. Oral L-arginine stimulates GLP-1 secretion to improve glucose tolerance in male mice.
Clemmensen C; Smajilovic S; Smith EP; Woods SC; Bräuner-Osborne H; Seeley RJ; D'Alessio DA; Ryan KK
Endocrinology; 2013 Nov; 154(11):3978-83. PubMed ID: 23959939
[TBL] [Abstract][Full Text] [Related]
8. CREB/CRTC2 controls GLP-1-dependent regulation of glucose homeostasis.
Lee JH; Wen X; Cho H; Koo SH
FASEB J; 2018 Mar; 32(3):1566-1578. PubMed ID: 29118086
[TBL] [Abstract][Full Text] [Related]
9. β-Cell Glucagon-Like Peptide-1 Receptor Contributes to Improved Glucose Tolerance After Vertical Sleeve Gastrectomy.
Garibay D; McGavigan AK; Lee SA; Ficorilli JV; Cox AL; Michael MD; Sloop KW; Cummings BP
Endocrinology; 2016 Sep; 157(9):3405-9. PubMed ID: 27501183
[TBL] [Abstract][Full Text] [Related]
10. Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in alpha2A-adrenoceptor knockout mice.
Savontaus E; Fagerholm V; Rahkonen O; Scheinin M
Eur J Pharmacol; 2008 Jan; 578(2-3):359-64. PubMed ID: 17964569
[TBL] [Abstract][Full Text] [Related]
11. Glucose Tolerance Is Improved in Mice Invalidated for the Nuclear Receptor HNF-4γ: A Critical Role for Enteroendocrine Cell Lineage.
Baraille F; Ayari S; Carrière V; Osinski C; Garbin K; Blondeau B; Guillemain G; Serradas P; Rousset M; Lacasa M; Cardot P; Ribeiro A
Diabetes; 2015 Aug; 64(8):2744-56. PubMed ID: 25829452
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 and beta cell glucose sensitivity - a glucose ramp study in mice.
Ahrén B
Peptides; 2021 Dec; 146():170650. PubMed ID: 34547355
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of parenteral GLP-1 delivery by cell therapy in insulin-deficient streptozotocin diabetic mice.
Vasu S; Moffett RC; McCluskey JT; Hamid MH; Irwin N; Flatt PR
Gene Ther; 2013 Nov; 20(11):1077-84. PubMed ID: 23784442
[TBL] [Abstract][Full Text] [Related]
16. L-cell Arntl is required for rhythmic glucagon-like peptide-1 secretion and maintenance of intestinal homeostasis.
Martchenko SE; Martchenko A; Biancolin AD; Waller A; Brubaker PL
Mol Metab; 2021 Dec; 54():101340. PubMed ID: 34520858
[TBL] [Abstract][Full Text] [Related]
17. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
[TBL] [Abstract][Full Text] [Related]
18. Oral 2-oleyl glyceryl ether improves glucose tolerance in mice through the GPR119 receptor.
Hassing HA; Engelstoft MS; Sichlau RM; Madsen AN; Rehfeld JF; Pedersen J; Jones RM; Holst JJ; Schwartz TW; Rosenkilde MM; Hansen HS
Biofactors; 2016 Nov; 42(6):665-673. PubMed ID: 27297962
[TBL] [Abstract][Full Text] [Related]
19. A Novel TGR5 Activator WB403 Promotes GLP-1 Secretion and Preserves Pancreatic β-Cells in Type 2 Diabetic Mice.
Zheng C; Zhou W; Wang T; You P; Zhao Y; Yang Y; Wang X; Luo J; Chen Y; Liu M; Chen H
PLoS One; 2015; 10(7):e0134051. PubMed ID: 26208278
[TBL] [Abstract][Full Text] [Related]
20. Transient receptor potential vanilloid 1 activation enhances gut glucagon-like peptide-1 secretion and improves glucose homeostasis.
Wang P; Yan Z; Zhong J; Chen J; Ni Y; Li L; Ma L; Zhao Z; Liu D; Zhu Z
Diabetes; 2012 Aug; 61(8):2155-65. PubMed ID: 22664955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
